Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
49.81
-2.51 (-4.80%)
Sep 29, 2026, 12:30 PM EDT - Market open
Pulse Biosciences Revenue
Pulse Biosciences had revenue of $434.00K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $1.19M. In the year 2025, Pulse Biosciences had annual revenue of $350.00K.
Revenue (ttm)
$1.19M
Revenue Growth
n/a
P/S Ratio
3,149.03
Revenue / Employee
$10,216
Employees
116
Market Cap
3.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 350.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 700.00K | -718.00K | -50.63% |
| Dec 31, 2021 | 1.42M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb | 5.32B |
| MiniMed Group | 3.22B |
| Envista Holdings | 2.86B |
| Teleflex | 2.25B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.58B |
| Stevanato Group | 1.40B |
| Warby Parker | 911.61M |
PLSE News
- 5 days ago - Pulse Biosciences management to meet virtually with Freedom Capital - TheFly
- 6 days ago - Pulse Biosciences initiated with a Buy at BTIG - TheFly
- 13 days ago - Pulse Biosciences falls -10.6% - TheFly
- 13 days ago - Pulse Biosciences falls -6.2% - TheFly
- 14 days ago - Pulse Biosciences announces two milestones in PRECISE-BTN study - TheFly
- 14 days ago - Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules - Business Wire
- 20 days ago - Pulse Biosciences rises 19.5% - TheFly
- 20 days ago - Pulse Biosciences initiated with a Buy at Freedom Capital - TheFly